NCT06730321

Brief Summary

To develop and validate a structured scoring tool (robotic thyroidectomy assessment score, RTAS) for assessing and quantifying surgical performance in robotic thyroidectomy (RT).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Dec 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Dec 2024Dec 2027

First Submitted

Initial submission to the registry

December 9, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 12, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

December 12, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

3.1 years

First QC Date

December 9, 2024

Last Update Submit

May 2, 2026

Conditions

Keywords

Robotic thyroidectomySurgical competencyRobotic thyroidectomy assessment score

Outcome Measures

Primary Outcomes (4)

  • Number of participants with recurrent laryngeal nerve injury

    impaired vocal cord mobility confirmed by postoperative laryngoscopy

    through study completion, an average of 1 year

  • Number of participants with hypoparathyroidism

    a postoperative parathyroid hormone level of less than 10 pg/ml

    through study completion, an average of 1 year

  • Operative time

    operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet

    through study completion, an average of 1 year

  • Score for surgical competence

    score evaluated by the proposed assessment system

    at the end of robotic thyroidectomy

Secondary Outcomes (2)

  • hospitalization

    through study completion, an average of 1 year

  • degree of pain

    approximately 4 hours after surgery and on postoperative day 1

Study Arms (1)

Patients underwent robotic thyroidectomy

Patients underwent robotic thyroidectomy without conversion during the study period

Other: Observations on clinicopathological factors influencing the assessment score of surgery

Interventions

Age, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data

Patients underwent robotic thyroidectomy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients were well informed about the robotic thyroidectomy and were aware of the potential benefits and risks. Patients underwent robotic thyroidectomy during the study period. Patient consented for us to use perioperative data.

You may qualify if:

  • Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
  • Clinical diagnosis of benign thyroid nodules with a maximum diameter not exceeding 6 cm
  • Participants with high cosmetic expectations
  • Participants underwent robotic thyroidectomy without open conversion

You may not qualify if:

  • Participants with history of neck surgery or radiation
  • Participants with vocal fold fixation by preoperative fibrolaryngoscope
  • Participants with preoperative examination suggestive of distant invasion
  • Participants with fusion or fixed of lymph nodes in the neck

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Sixth People's Hospital

Shanghai, 200233, China

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsThyroid NoduleThyroid DiseasesThyroid Cancer, PapillaryThyroid cancer, follicular

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesAdenocarcinoma, PapillaryAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Officials

  • Ling Zhan, Doctor

    Shanghai 6th People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

December 9, 2024

First Posted

December 12, 2024

Study Start

December 12, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

May 7, 2026

Record last verified: 2026-05

Locations